(Q45417490)

English

DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner

scientific article published on 19 April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

author name string

Darren S Miller

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Ieva Kotlarski

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Allison R Jilbert

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

19 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

351

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

159-169

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Toll-like receptors: critical proteins linking innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

Translation of immunological knowledge into better treatments of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

FDA Approves Hepatitis B Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

A duck hepatitis B virus strain with a knockout mutation in the putative X ORF shows similar infectivity and in vivo growth characteristics to wild-type virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

Early life humoral response of ducks to DNA immunization against hepadnavirus large envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

Maternally transferred antibodies from DNA-immunized avians protect offspring against hepadnavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

Sequence comparison of an Australian duck hepatitis B virus strain with other avian hepadnaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

Circulating immune complexes in chronic hepatitis related to hepatitis C and B viruses infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

Immunoglobulin- and hepatitis B surface antigen-specific circulating immune complexes in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.037

7 January 2021

Identifiers

10.1016/J.VIROL.2006.02.037

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45417490&oldid=2151520748"